Sabrina Pricl

Sabrina Pricl

Università degli Studi di Trieste

H-index: 60

Europe-Italy

About Sabrina Pricl

Sabrina Pricl, With an exceptional h-index of 60 and a recent h-index of 33 (since 2020), a distinguished researcher at Università degli Studi di Trieste, specializes in the field of Nanotechnology, engineering, target therapy, cancer, molecular biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Molecular Ballet: Investigating the Complex Interaction between Self-Assembling Dendrimers and Human Serum Albumin via Computational and Experimental Methods

[18F]Fluspidine—A PET Tracer for Imaging of σ1 Receptors in the Central Nervous System

Targeted drug delivery: concepts, approaches, and applications

Biophysical and docking study on the interaction of anticancer drugs encorafenib and binimetinib with human serum albumin

The cyclic peptide G4CP2 enables the modulation of galactose metabolism in yeast by interfering with GAL4 transcriptional activity

The Spicy Science of Dendrimers in the Realm of Cancer Nanomedicine: A Report from the COST Action CA17140 Nano2Clinic

Transformations of L-DOPA during the synthesis of gold-based nanodelivery systems for LAT-1 targeting

Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers

Sabrina Pricl Information

University

Position

___

Citations(all)

13182

Citations(since 2020)

4729

Cited By

11059

hIndex(all)

60

hIndex(since 2020)

33

i10Index(all)

227

i10Index(since 2020)

136

Email

University Profile Page

Università degli Studi di Trieste

Google Scholar

View Google Scholar Profile

Sabrina Pricl Skills & Research Interests

Nanotechnology

engineering

target therapy

cancer

molecular biology

Top articles of Sabrina Pricl

Title

Journal

Author(s)

Publication Date

Molecular Ballet: Investigating the Complex Interaction between Self-Assembling Dendrimers and Human Serum Albumin via Computational and Experimental Methods

Pharmaceutics

Gabriele Cavalieri

Domenico Marson

Nicoletta Giurgevich

Rachele Valeri

Fulvia Felluga

...

2024/4/12

[18F]Fluspidine—A PET Tracer for Imaging of σ1 Receptors in the Central Nervous System

Friedrich-Alexander Ludwig

Erik Laurini

Judith Schmidt

Sabrina Pricl

Winnie Deuther-Conrad

...

2024/1/28

Targeted drug delivery: concepts, approaches, and applications

Maria Russi

Domenico Marson

Erik Laurini

Sabrina Pricl

2024/1/1

Biophysical and docking study on the interaction of anticancer drugs encorafenib and binimetinib with human serum albumin

European Journal of Pharmaceutical Sciences

Gabriele Cavalieri

Giulia Cilurzo

Lorenzo Pettorosso

Andrea Mansueto

Erik Laurini

...

2023/10/1

The cyclic peptide G4CP2 enables the modulation of galactose metabolism in yeast by interfering with GAL4 transcriptional activity

Frontiers in Molecular Biosciences

Stefano Rosa

Andrea Tagliani

Chiara Bertaso

Luca Tadini

Cristina Visentin

...

2023/3/1

The Spicy Science of Dendrimers in the Realm of Cancer Nanomedicine: A Report from the COST Action CA17140 Nano2Clinic

Sabrina Pricl

2023/7/24

Transformations of L-DOPA during the synthesis of gold-based nanodelivery systems for LAT-1 targeting

Nikolina Kalčec

Antonio Ljulj

Lucija Božičević

Valerije Vrček

Domenico Marson

...

2023

Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers

Proceedings of the National Academy of Sciences

Jiaxuan Chen

Dandan Zhu

Baoping Lian

Kangjie Shi

Peng Chen

...

2023/5/23

Aquasomes: a novel nanocarrier system for drug delivery

Gwaza Eric Ayom

Nyemaga Masanje Malima

Shesan John Owonubi

Neerish Revaprasadu

2023/1/1

Site-specific drug delivery utilizing monoclonal antibodies

Domenico Marson

Maria Russi

Alice Fermeglia

Erik Laurini

Sabrina Pricl

2023/1/1

Conformationally Restricted σ1 Receptor Antagonists from (−)-Isopulegol

Journal of Medicinal Chemistry

Luca Blicker

Rafael González-Cano

Erik Laurini

Francisco R Nieto

Judith Schmidt

...

2023/3/22

Azacalixphyrin nanostructures

Journal of Porphyrins and Phthalocyanines

Daniel Ferry

Sabrina Pricl

Domenico Marson

Zhongrui Chen

Gabriel Canard

...

2023

Abstract C153: Rare BRAF mutations in menlanoma and beyond: Rationalizing the afficacy of B-raf inhibitors via HPC-based in silico/in vitro investigations

Molecular Cancer Therapeutics

Sabrina Pricl

Erik Laurini

Domenico Marson

Gabriele Cavalieri

2023/12/1

Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease

European Journal of Medicinal Chemistry

Michele Tonelli

Marco Catto

Raimon Sabaté

Valeria Francesconi

Erik Laurini

...

2023/3/15

Some things old, new and borrowed: Delivery of dabrafenib and vemurafenib to melanoma cells via self-assembled nanomicelles based on an amphiphilic dendrimer

European Journal of Pharmaceutical Sciences

Maria Russi

Rachele Valeri

Domenico Marson

Chiara Danielli

Fulvia Felluga

...

2023/1/1

Nanovesicles for the delivery of cardiovascular drugs

Domenico Marson

Suzana Aulic

Alice Fermeglia

Erik Laurini

Sabrina Pricl

2022/1/1

A self-assembling prodrug nanosystem to enhance metabolic stability and anticancer activity of gemcitabine

Chinese Chemical Letters

Mei Cong

Guangling Xu

Shaoyou Yang

Jing Zhang

Wenzheng Zhang

...

2022/5/1

Novel epigenetic therapeutic strategies and targets in cancer

Quratulain Babar

Ayesha Saeed

Tanveer A Tabish

Sabrina Pricl

Helen Townley

...

2022/12/1

Cubosomes: a promising vesicular system for drug delivery

Domenico Marson

Suzana Aulic

Erik Laurini

Sabrina Pricl

2022/1/1

Binding of the B-Raf inhibitors dabrafenib and vemurafenib to human serum albumin: a biophysical and molecular simulation study

Molecular Pharmaceutics

Maria Russi

Gabriele Cavalieri

Domenico Marson

Erik Laurini

Sabrina Pricl

2022/4/18

See List of Professors in Sabrina Pricl University(Università degli Studi di Trieste)